Lutter, J. ; Lukas, M. ; Schwarzkopf, L. ; Jörres, R.A.* ; Studnicka, M.* ; Kahnert, K.* ; Karrasch, S. ; Bewig, B.* ; Vogelmeier, C.F.* ; Holle, R.
Utilization and determinants of use of non-pharmacological interventions in COPD: Results of the COSYCONET cohort.
Respir. Med. 171:106087 (2020)
Background: Guidelines for chronic obstructive pulmonary disease (COPD) recommend supplementing pharmacotherapy with non-pharmacological interventions. Little is known about the use of such interventions by patients. We analyzed the utilization of a number of non-pharmacological interventions and identified potential determinants of use.Methods: Based on self-reports, use of interventions (smoking cessation, influenza vaccination, physiotherapy, sports program, patient education, pulmonary rehabilitation) and recommendation to use were assessed in 1410 patients with COPD. The utilization was analyzed according to sex and severity of disease. Potential determinants of utilization included demographic variables and disease characteristics and were analyzed using logistic regression models.Results: Influenza vaccination in the previous autumn/winter was reported by 73% of patients. About 19% were currently participating in a reimbursed sports program, 10% received physiotherapy, 38% were ever enrolled in an educational program, and 34% had ever participated in an outpatient or inpatient pulmonary rehabilitation program. Out of 553 current or former smokers, 24% had participated in a smoking cessation program. While reports of having received a recommendation to use mainly did not differ according to sex, women showed significantly (p < 0.05) higher utilization rates than men for all interventions except influenza vaccination. Smoking was a predictor for not having received a recommendation for utilization and also significantly associated with a reduced odds of utilization. We found a correlation between recommendation to use and utilization.Conclusions: Utilization of non-pharmacological interventions was lower in men and smokers. A recommendation or offer to use by the physician could help to increase uptake.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Treatment Guidelines ; Non-pharmacological Intervention ; Gender Differences ; Vaccination ; Smoking Cessation; Obstructive Pulmonary-disease; Health-care Utilization; Gender-differences; Respiratory Society; Smoking-cessation; Management; Costs; Population; Guideline; Diagnosis
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2020
Prepublished im Jahr
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
0954-6111
e-ISSN
1532-3064
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 171,
Heft: ,
Seiten: ,
Artikelnummer: 106087
Supplement: ,
Reihe
Verlag
Elsevier
Verlagsort
32 Jamestown Rd, London Nw1 7by, England
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30202 - Environmental Health
80000 - German Center for Lung Research
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-505300-002
G-501800-533
G-505300-001
G-504000-009
G-501800-401
Förderungen
GlaxoSmithKline
Novartis Deutschland GmbH
Grifols Deutschland GmbH
Boehringer Ingelheim Pharma GmbH Co. KG
AstraZeneca GmbH
BMBF
German Centre for Lung Research (DZL)
Copyright
Erfassungsdatum
2020-09-28